Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Net Margin (2024 - 2025)

Connect Biopharma Holdings' Net Margin history spans 2 years, with the latest figure at 107500.0% for Q3 2025.

  • For Q3 2025, Net Margin fell 10644372.0% year-over-year to 107500.0%; the TTM value through Sep 2025 reached 6901.54%, down 635011.0%, while the annual FY2024 figure was 60.03%, N/A changed from the prior year.
  • Net Margin for Q3 2025 was 107500.0% at Connect Biopharma Holdings, down from 1275.93% in the prior quarter.
  • Across five years, Net Margin topped out at 1056.28% in Q3 2024 and bottomed at 107500.0% in Q3 2025.